BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/27/2014 5:15:00 PM | Browse: 1018 | Download: 1149
 |
Received |
|
2013-09-28 18:19 |
|
Peer-Review Started |
|
2013-09-29 15:18 |
 |
First Decision by Editorial Office Director |
|
|
|
Return for Revision |
|
2013-11-15 15:21 |
|
Revised |
|
2013-11-29 16:54 |
|
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2014-02-20 15:30 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2014-02-20 15:57 |
|
Articles in Press |
|
|
|
Edit the Manuscript by Language Editor |
|
2014-04-18 14:07 |
|
Typeset the Manuscript |
|
2014-05-05 10:21 |
|
Publish the Manuscript Online |
|
2014-05-18 12:31 |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Topic Highlights |
| Article Title |
Optimal treatment strategy for Helicobacter pylori: Era of antibiotic resistance
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Jun Heo and Seong Woo Jeon |
| Funding Agency and Grant Number |
|
| Corresponding Author |
Seong Woo Jeon, MD, PhD, Department of Internal Medicine, Kyungpook National University Hospital Medical Center, 807, Hokuk-Ro, Book-Gu, Daegu 702-911, South Korea. sw-jeon@hanmail.net |
| Key Words |
Helicobacter pylori; Standard therapy; Bacterial eradication; Concomitant therapy; Hybrid therapy |
| Core Tip |
Currently, among the alternative first-line eradication regimens, concomitant and hybrid regimens have shown excellent results and could be the optimal treatment option. Levofloxacin-based quadruple therapy has shown promise as a rescue treatment. |
| Publish Date |
2014-05-18 12:31 |
| Citation |
Heo J, Jeon SW. Optimal treatment strategy for Helicobacter pylori: Era of antibiotic resistance. World J Gastroenterol 2014; 20(19): 5654-5659
|
| URL |
http://www.wjgnet.com/1007-9327/full/v20/i19/5654.htm |
| DOI |
http://dx.doi.org/10.3748/wjg.v20.i19.5654 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
